Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Por Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
Publicado no Ther Adv Med Oncol (2016)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Publicado em 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Publicado em 2006

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Por Zoli, Wainer, Ulivi, Paola, Tesei, Anna, Fabbri, Francesco, Rosetti, Marco, Maltoni, Roberta, Giunchi, Donata Casadei, Ricotti, Luca, Brigliadori, Giovanni, Vannini, Ivan, Amadori, Dino
Publicado em 2005

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer

Por Maltoni, Roberta, Casadio, Valentina, Ravaioli, Sara, Foca, Flavia, Tumedei, Maria Maddalena, Salvi, Samanta, Martignano, Filippo, Calistri, Daniele, Rocca, Andrea, Schirone, Alessio, Amadori, Dino, Bravaccini, Sara
Publicado no Oncotarget (2017)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study

Por Mercatali, Laura, Ricci, Marianna, Scarpi, Emanuela, Serra, Patrizia, Fabbri, Francesca, Ricci, Rossana, Liverani, Chiara, Zanoni, Michele, Zoli, Wainer, Maltoni, Roberta, Gunelli, Erica, Amadori, Dino, Ibrahim, Toni
Publicado em 2013